Pediatric EBGLYSS trial meets endpoints in dermatitis care; Broader immunology portfolio gains attention beyond metabolic therapies; Recent share movement frames respo ...
Medicaid/CHIP surveillance demonstrated an 11.4% relative rise in pediatric diabetes prevalence, including a 24.3% increase in type 2 diabetes, with disparities by geography, sex, and region.